… The perceived importance of barriers to implement PGx testing in clinical practice, … for the
use of PGx in clinical practice, b) the insufficient awareness of PGx among clinicians, and c) the …

… and personalized medicine in clinical and research settings. … application of pharmacogenomics
into the clinical practice is … ethical issues related to the inclusion of pharmacogenomics …

… of PGx is related to clinical practice, many pharmacists lack … Clinical Pharmacogenetics
Implementation Consortium (CPIC) guidelines exist. Similar issues may exist for other clinicians. …

… Implementing PGx knowledge into routine clinical practice is merited once robust evidence
… alleles on drug function and corresponding clinical dosing modifications can be made to …

… clinical pharmacogenomic services in Thailand, emphasize the pharmacogenomics
implementation issues … for the implementation of pharmacogenomics into clinical practice. …

… used by the Mayo Clinic to implement PGx in the clinical setting. We define … clinical practice
and addressed not only the technical issues but also the knowledge and educational issues …

… testing and introduction into clinical practice is not optimal. A clear economic incentive
could be very important in leveling some of the barriers to clinical implementation, but cost-…

… We think we see evidence of this in clinical practice. For … the potential barriers and challenges
to test implementation at the … views about pharmacogenomics among clinicians serving AI/…

… issues that limited testing capabilities, the surveys also had some findings had implications
about the suggested challenges to the translation of pharmacogenetics in the clinical setting. …

… Aim: This study aims to assess the attitudes and opinions of clinicians practicing in psychiatry
toward pharmacogenomic testing, and in so doing elicits possible barriers and risks to …